Spread the love

Pune, July 23, 2020: The rise in the coronavirus cases in Mumbai and Pune will contribute in testing the efficiency of the vaccine developed in Oxford University and Astrazeneca said by the Serum Institute of India. 

Officials of the Serum Institute said that by the end of August the vaccine will be tested on almost 4000-5000 people across these two regions. Serum Institute is the local manufacturer of the vaccine in partnership with Oxford University. The institute will conduct trials to ensure that the vaccine is safe and suitable for Indians.

Adar Poonawalla said that the vaccine will be tested on the selected hotspot areas of Mumbai and Pune to determine its efficiency. 

Related Posts

SP College introduces online certificate course “Ayurveda and Yoga for Good Life” in collaboration with Home Yoga Guru

Hinjewadi village to be developed on the lines of Navi Mumbai

Huge blast at Lebanon’s capital city Beirut

Red alert announced in Mumbai due to heavy rain

Import of TV licensed in India to support domestic production

India extends lockdown till August 31 with certain relaxations


Reply comment

Your email address will not be published. Required fields are marked *